侵袭性催乳素垂体瘤经内镜切除术后早期催乳素缓解因素分析
董峻东， 裴玉康， 纪培志， 苗发安， 张慧， 张桐… - 徐州医科大学 …, 2024 - xb.xzhmu.edu.cn
… of aggressive prolactinomas. Methods A total of 141 patients with aggressive prolactinomas
who … Results Among the 141 patients undergoing surgery for aggressive prolactinomas, 121 …
who … Results Among the 141 patients undergoing surgery for aggressive prolactinomas, 121 …
垂体腺瘤中六氧-甲基鸟嘌呤-DNA-甲基转移酶的表达及其与垂体腺瘤侵袭性的关系
蒋小兵， 胡斌， 范翔， 何东升， 毛志钢， 陈沐… - 四川大学学报(医学 …, 2013 - ykxb.scu.edu.cn
… with the aggressiveness and relapse of pituitary adenomas. Prolactinomas are more likely
to … become an alternative treatment for aggressive and dopamine resistant prolactinomas. …
to … become an alternative treatment for aggressive and dopamine resistant prolactinomas. …
难治性泌乳素瘤药物治疗进展
牙森， 吴永刚 - 中国肿瘤临床, 2020 - cjco.cn
… prolactinomas pose a great challenge to neurosurgeons. Refractory prolactinomas …
exploratory drug treatment for refractory prolactinomas in addition to conventional treatment, …
exploratory drug treatment for refractory prolactinomas in addition to conventional treatment, …
侵袭性垂体瘤治疗方法的研究进展
刘红艳， 谷伟军， 母义明 - 解放军医学院学报, 2023 - xuebao.301hospital.com.cn
… Temozolomide is recommended as first-line chemotherapy drug for aggressive pituitary …
Research advances in treatment of aggressive pituitary adenomas[J]. Acad J Chin PLA Med …
Research advances in treatment of aggressive pituitary adenomas[J]. Acad J Chin PLA Med …
垂体催乳素瘤的临床特点及诊治要点更新——基于《 2022 版ICCE/AME 垂体催乳素瘤临床实践共识》 解读
谭惠文， 李丹婷， 余叶蓉 - 中国全科医学, 2024 - chinagp.net
… of pituitary prolactinoma. This article provides an update on the diagnosis and treatment of
… prolactinoma, special populations,dopamine agonist resistance,and invasive prolactinoma …
… prolactinoma, special populations,dopamine agonist resistance,and invasive prolactinoma …
替莫唑胺在垂体腺瘤治疗中的应用及进展.
林益光， 刘晓民 - Chinese Journal of Contemporary …, 2015 - search.ebscohost.com
… The aggressive pituitary adenomas show invasive … The therapy of aggressive pituitary
adenomas by temozolomide and … advance of the therapy of aggressive pituitary adenomas by …
adenomas by temozolomide and … advance of the therapy of aggressive pituitary adenomas by …
激素表达差异性垂体癌
鲁涛， 王任直， 朱朝晖， 钟定荣 - 中国现代神经疾病 …, 2015 - journal11.magtechjournal.com
… Stroke associated with pituitary apoplexy in a giant prolactinoma: a case report. Clin
Neurol Neurosurg, 2014, 116:101⁃103. Tjörnstrand A, Gunnarsson K, Evert M, Holmberg E, …
Neurol Neurosurg, 2014, 116:101⁃103. Tjörnstrand A, Gunnarsson K, Evert M, Holmberg E, …
《 欧洲内分泌学会临床实践指南: 妊娠期功能性和无功能性垂体腺瘤》 指南解读
邓臣前， 班江丽， 陈树春 - 中国全科医学, 2022 - chinagp.net
… surgery in patients with prolactinomas:a metaanalysis[J]. Clin … first-line treatment for
prolactinoma patients. A systematic review … Growth of an aggressive tumor during pregnancy in an …
prolactinoma patients. A systematic review … Growth of an aggressive tumor during pregnancy in an …
[PDF][PDF] 化痰祛瘀中药联合溴隐亭含药血清抑制泌乳素垂体瘤细胞增殖的体外研究
施扬， 夏兆云， 刘慧瑛， 张秋娟， 陆征宇 - 世界临床药物, 2020 - jwph.com.cn
: 目的探索化痰祛瘀中药联合溴隐亭含药血清对体外培养泌乳素垂体瘤细胞增殖的影响及其作用
机制. 方法以大鼠垂体瘤细胞系MMQ 作为研究对象. 细胞分为空白对 组, 空白血清组, 溴隐亭…
机制. 方法以大鼠垂体瘤细胞系MMQ 作为研究对象. 细胞分为空白对 组, 空白血清组, 溴隐亭…
基于微生物-肠-脑轴探索神经递质在脑恶性肿瘤中的研究进展
梁飞， 孙逸初， 夏铀铀 - 中国肿瘤临床, 2023 - cjco.cn
: 微生物-肠-脑轴(microbiota-gut-brain axis, MGBA) 是由神经, 内分泌和免疫系统相互作用而构成
的复杂网络, 为揭示肠道菌群如何影响脑恶性肿瘤的生物学特性提供了关键的理论框架. 然而, …
的复杂网络, 为揭示肠道菌群如何影响脑恶性肿瘤的生物学特性提供了关键的理论框架. 然而, …